In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Excaliard Pharmaceuticals, Inc.

Latest From Excaliard Pharmaceuticals, Inc.

Pfizer's Discerning Predator: CEO Ian Read

Metabolic Disorders Cancer

Isis and antisense make gains in 2013

Isis Pharmaceuticals founder, CEO and chairman Stanley Crooke knew it would take decades for antisense to prove itself. And while it's taken a few more years than expected for others to acknowledge the technology's potential, 2013 has been a good year for antisense in general and Isis in particular.

Metabolic Disorders Infectious Diseases

Deals Shaping The Medical Industry, November 2012

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device

Novo and Novartis funds back $16m Series A for US dermatology startup Thesan

Two pharma-backed venture investment firms put $16 million into a Series A round for a new Southern California dermatology drug company called Thesan Pharmaceuticals, which is run by Gordon Foulkes - the former CEO of San Diego startup Excaliard Pharmaceuticals that Pfizer acquired in 2011 (, 23 November 2011).

Orthopedics Inflammation
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
  • Other Names / Subsidiaries
    • Pfizer Inc.
    • Excaliard Pharmaceuticals Inc.